2000/477/EC: Commission Decision of 24 July 2000 for purchase by the Community of Bluetongue vaccine for emergency stock (notified under document number C(2000) 2209)

• Articles: 5

Article 1

1. For emergency use the Community shall make arrangements for the purchase of 500000 doses of trivalent bluetongue vaccine containing serotypes 4, 9 and 16 and 500000 doses of monovalent Bluetongue vaccine (serotype 2).

2. The arrangements referred to in paragraph 1 shall include the storage of vaccines in such a manner that they can be dispatched without delay to the area designated for vaccination.

Article 2

The maximum cost of the measures referred to in Article 1 shall be up to EUR 160000.

Article 3

1. To meet the objectives of Articles 1 and 2 the Commission shall conclude contracts without delay with the laboratory of Ondertesport in South-Africa.

2. The Director General of the Directorate General for Health and Consumer Protection shall be authorised to sign the contracts on behalf of the European Commission.

Article 4

Decision 2000/292/EC(3) of 6 April 2000 is repealed.

Article 5

This Decision is addressed to all the Member States.

Done at Brussels, 24 July 2000.

For the Commission

David Byrne

Member of the Commission

(1) OJ L 224, 18.8.1990, p. 19.

(2) OJ L 160, 26.6.1999, p. 103.

(3) OJ L 95, 15.4.2000, p. 39.